Photo by nci from unsplash
Precise evaluation of proliferative activity is essential for the stratified treatment of luminal‐type breast cancer (BC). Immunohistochemical staining of Ki‐67 has been widely used to determine proliferative activity and is… Click to show full abstract
Precise evaluation of proliferative activity is essential for the stratified treatment of luminal‐type breast cancer (BC). Immunohistochemical staining of Ki‐67 has been widely used to determine proliferative activity and is recognised to be a useful prognostic marker. However, there remains discussion concerning the methodology. We aimed to develop an automated and reliable Ki‐67 assessment approach for invasive BC.
Keywords:
breast;
automated assessment;
cancer utility;
assessment breast;
breast cancer
Journal Title: Histopathology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Histopathology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!